The June 2014 update to the New Zealand Pharmaceutical Schedule is now available. There is one new listing this month; febuxostat (Adenuric) for patients with gout.  PHARMAC has not disclosed when the funding application to list febuxostat in the New Zealand Pharmaceutical Schedule was made.

There are no additions/changes that relates to funding applications submitted to PHARMAC before 2014. PHARMAC is yet to publish details on funding applications made/received in 2014.